(Q48160439)

9 February 2018

title

Activation of microglial cells by the CD40 pathway: relevance to multiple sclerosis. (English)

1 reference

9 February 2018

0 references

1 reference

9

1 reference

9 February 2018

author name string

Tan J

1

1 reference

9 February 2018

Town T

2

1 reference

9 February 2018

Paris D

3

1 reference

9 February 2018

Placzek A

4

1 reference

9 February 2018

Parker T

5

1 reference

9 February 2018

Crawford F

6

1 reference

9 February 2018

Yu H

7

1 reference

9 February 2018

Humphrey J

8

1 reference

9 February 2018

publication date

1 June 1999

1 reference

9 February 2018

Journal of Neuroimmunology

published in

1 reference

9 February 2018

volume

97

1 reference

9 February 2018

issue

1-2

1 reference

9 February 2018

page(s)

77-85

1 reference

9 February 2018

Molecular and biological characterization of a murine ligand for CD40

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900053-3

7 January 2021

Increased interleukin 12 production in progressive multiple sclerosis: induction by activated CD4+ T cells via CD40 ligand

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900053-3

7 January 2021

Increased production of interferon gamma and tumor necrosis factor precedes clinical manifestation in multiple sclerosis: do cytokines trigger off exacerbations?

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900053-3

7 January 2021

Suppression of murine thyroiditis via blockade of the CD40-CD40L interaction

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900053-3

7 January 2021

Mature microglia resemble immature antigen-presenting cells

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900053-3

7 January 2021

Inducible nitric oxide synthase activity of cloned murine microglial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900053-3

7 January 2021

Assessment of intracellular TAP-1 and TAP-2 in conjunction with surface MHC class I in plasma cells from patients with multiple myeloma

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900053-3

7 January 2021

Cell death and birth in multiple sclerosis brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900053-3

7 January 2021

gp39-CD40 interactions are essential for germinal center formation and the development of B cell memory

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900053-3

7 January 2021

The application of multifactorial cluster analysis in the staging of plaques in early multiple sclerosis. Identification and characterization of the primary demyelinating lesion.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900053-3

7 January 2021

CD40-CD40 ligand interactions in experimental allergic encephalomyelitis and multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900053-3

7 January 2021

Requirement for CD40 ligand in costimulation induction, T cell activation, and experimental allergic encephalomyelitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900053-3

7 January 2021

Activated human T cells express a ligand for the human B cell-associated antigen CD40 which participates in T cell-dependent activation of B lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900053-3

7 January 2021

The cytokine storm in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900053-3

7 January 2021

Immunological aspects of demyelinating diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900053-3

7 January 2021

Recombinant soluble trimeric CD40 ligand is biologically active

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900053-3

7 January 2021

Post-transcriptional inhibition of CD40 gene expression in microglia by transforming growth factor-beta

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900053-3

7 January 2021

Nitric oxide via an inducible isoform of nitric oxide synthase is a possible factor to eliminate inflammatory cells from the central nervous system of mice with experimental allergic encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900053-3

7 January 2021

Accessory signaling by CD40 for T cell activation: induction of Th1 and Th2 cytokines and synergy with interleukin-12 for interferon-gamma production

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900053-3

7 January 2021

Cytokine secretion and nitric oxide production by mononuclear cells of patients with multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900053-3

7 January 2021

Leukocyte chemotactic factor, a natural ligand to CD4, is expressed by lymphocytes and microglial cells of the MS plaque

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900053-3

7 January 2021

Blocking the CD40L-CD40 interaction in vivo specifically prevents the priming of T helper 1 cells through the inhibition of interleukin 12 secretion

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900053-3

7 January 2021

A method for large-scale production of mouse brain cortical cultures.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900053-3

7 January 2021

Interferon-gamma-inducing factor elicits antitumor immunity in association with interferon-gamma production

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900053-3

7 January 2021

Mice deficient for the CD40 ligand

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900053-3

7 January 2021

10.1016/S0165-5728(99)00053-3

Identifiers

DOI

1 reference

9 February 2018

PubMed ID

10408982

1 reference

9 February 2018